Therapeutic plasma exchange: a second‐line treatment for brodifacoum poisoning following an anaphylactoid reaction to vitamin K

Vitamin K1 is the first‐line therapy to brodifacoum poisoning. Anaphylactoid reactions may occur anytime during intravenous administration of vitamin K1 injection. Vitamin K1 must be ceased when anaphylactoid reactions emerge, and therapeutic plasma exchange could be a second‐line option.

Detalles Bibliográficos
Autores principales: Deng, Ying, Qiu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224774/
https://www.ncbi.nlm.nih.gov/pubmed/28096987
http://dx.doi.org/10.1002/ccr3.756
Descripción
Sumario:Vitamin K1 is the first‐line therapy to brodifacoum poisoning. Anaphylactoid reactions may occur anytime during intravenous administration of vitamin K1 injection. Vitamin K1 must be ceased when anaphylactoid reactions emerge, and therapeutic plasma exchange could be a second‐line option.

Ejemplares similares